Federal Health Insurance Web Portal


HOME

merchandise

in the news

The Chronicity Project

Advocacy for Patients Blog

HELPFUL LINKS

health insurance

prescription drug plans

IVIg Patient Resource Center

social security disability

educational equity

employment

miscellaneous resources

facebook
twitter

OUR PARTNERS

GYGIG

Privacy Policy





INFORMATION PERTAINING TO SPECIFIC DISEASES


CIDP

CIDP Sample Appeal Letter

CIDP Haq

CIDP Latov

CIDP Magda

CIDP Sander

CIDP Sharma

For more information about CIDP, see the GBS/CIDP Foundation International



Guillain Barre Syndrome

Guillain Barre Sample Appeal Letter

GBS Donofrio

GBS Elovaara

GBS Harel

GBS Hughes 1

GBS Hughes 2

GBS Hughes 3

GBS Korinthenberg

GBS Kuitwaard

GBS Lindenbaum

GBS Mayo Clinic

GBS NINDS

GBS Van Doorn

GBS Wiles

GBS Yata

Aetna Policy

CIGNA Criteria

Anthem Policy

For more information about Guillain Barre Syndrome, see GBS/CIDP Foundation International



Inclusion Body Myositis

Inclusion Body Myositis Sample Appeal Letter

IBM Dalakas 1997

IBM Dalakas 2001

IBM Engel

IBM Mukunda

IBM Recher

IBM Walter

IBM Myo Pongratz

UnitedHealthcare Policy

For more information, see The Myositis Organization



Lupus

Lupus Sample Appeal Letter

Ballow lupus

Corvetta lupus

Goodfield lupus

Kamali lupus

Levy lupus

Meissner lupus

Perricone lupus

Sherer lupus

Shoenfield lupus

Toubi lupus

Winder Lupus

Zandman-Goddard lupus

Zandman-Goddard lupus 2

For more information about lupus, see the Lupus Foundation of America



Multiple Sclerosis

MS Sample Appeal Letter 1

MS Sample Appeal Letter 2

MS Sample Appeal Letter 3

MS IVIg for RRMS Literature Summary

MS Independent Review Organization Decision

MS American Academy of Neuropathy Guidelines

MS NINDS

MS Achiron 1

MS Achiron 2

MS Achiron 3

MS Achiron 4

MS Achiron 5

MS Advances

MS Fazekas 1

MS Fazekas 2

MS Info Sourcebook

MS Katz 1

MS Katz 2

MS Poehlau

MS Science Daily

MS Sorensen 1

MS Sorensen 2

MS Sorensen 3

MS Sorensen 4

MS Strasser-Fuchs

MS Vallat

MS Aetna

MS CIGNA

MS BCBS of TX

MS United Healthcare

For more information about multiple sclerosis, see the National Multiple Sclerosis Society



Neuromyelitis Optics (NMO or Devic's Disease)

NMO Sample appeal letter

IVIg Aetna

Bakker, Metz NMO

Devic's - TM Association

Ii NMO

Jacob NMO

NIH NMO Page

Nimmerjahn

Okada NMO

Tselis NMO

What is IVIg?

Wiles NMO

Wingerchuk NMO

For more information about NMO, see the Guthy Jackson Charitable Foundation



Pemphigus Vulgaris

Pemphigus Sample appeal letter

Pemphigus Amagai

Pemphigus Arnold

Pemphigus Bystryn

Pemphigus Czernik

Pemphigus Green

Pemphigus Mignogna

Pemphigus Mignogna 2

Pemphigus Ruetter

Pemphigus Sami

For more information about Pemphigus Vulgaris, see the International Pemphigus and Pemphigoid Foundation



Polymositis

Polymositis Sample Appeal Letter

Poly Cherin

Poly Donofrio

Poly Elovaara

Poly Greenberg

Poly Grenevay

Poly Illa

Poly NINDS

Poly Saito

Poly Wada

Aetna Policy

Anthem Policy

CIGNA criteria

United Healthcare Policy

For further information, please see the Myosotis Association of America



Recurrent In Vitro Fertilization Failure

IVF Sample Appeal Letter

IVF Clark

IVF Coulam

IVF Hutton

IVF Konova

IVF RCOG

IVF Stern

IVF Stricker

IVF van den Heuvel

Cigna Policy

For more information, contact the American Pregnancy Association



Transverse Myelitis

Transverse Myelitis Sample Appeal Letter

Transverse Myelitis Bhinder

Transverse Myelitis Children's Hospital

Transverse Myelitis Fonseca

Transverse Myelitis Kerr

Transverse Myelitis Krishnan

Transverse Myelitis Li

Transverse Myelitis Marchioni

Transverse Myelitis Mayo Clinic

Transverse Myelitis Murai

Transverse Myelitis NINDS

For more information, contact the Transverse Myelitis Association



PLEASE NOTE: Nothing on this website should be construed as medical or legal advice. It is informational only. If you have questions about whether IVIg is right for you, seek the advice of a licensed health care provider. There may be adverse reactions to IVIg, as well as drug interactions of which you should be aware before beginning treatment. Speak with your physician for more information.